OVERVIEW
IGF-1_LR3 is a research peptide used in preclinical laboratory models involving metabolic, mitochondrial, immune, or regenerative pathways.
What is it?
IGF-1 LR3 is a synthetic analog of insulin-like growth factor 1 developed for investigational and in vitro research use. It incorporates structural modifications, including an extended amino acid sequence and reduced binding affinity to IGF-binding proteins, which are intended to prolong molecular activity and stability in experimental settings.
In preclinical and laboratory research models, IGF-1 LR3 has been examined for its interaction with IGF-1 receptor signaling pathways involved in cellular growth, proliferation, and nutrient-related anabolic signaling. These characteristics have made it a compound of interest in experimental studies exploring muscle cell biology, tissue growth signaling, and metabolic adaptation mechanisms.
MECHANISM OF INTEREST
|
Pathway |
Description |
|
Angiogenesis |
Observed to influence vascular endothelial pathways. |
|
Tissue Repair |
Supports modeling of gastric, tendon, and muscular healing. |
|
Cytoprotection |
Evaluated for protective effects in oxidative environments. |
KEY RESEARCH APPLICATIONS
- Tissue repair and regeneration research
- Inflammation pathway modeling
- Angiogenesis studies
SPECIFICATIONS
|
Attribute |
Detail |
|
Purity |
≥ 98% (HPLC) |
|
Form |
Lyophilized peptide |
|
Appearance |
White to off-white powder |
|
Molecular Weight |
~1419 Da |
|
Container |
Sterile glass vial |
HANDLING & STORAGE
Lyophilized: Store at –20°C, protect from light and moisture.
Reconstituted: Store at 2–8°C, avoid freeze–thaw cycles.
RESEARCH USE ONLY
This product is supplied strictly for laboratory, research, and development use. Not for human consumption or therapeutic application.
